Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22714001 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)
Condition: Hepatitis C Infection
Interventions: Drug: Daclatasvir;   Drug: Placebo;   Drug: Peginterferon alpha-2a;   Drug: ribavirin

Indicates status has not been verified in more than two years